UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share (URGN)

161 filings reported holding URGN - UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share as of Q1 2025.
UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share (URGN) has 139 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 41.6M shares of 46.2M outstanding shares and own 90.06% of the company stock.
Largest 10 shareholders include UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC (4.36M shares), RTW INVESTMENTS, LP (3.83M shares), RA CAPITAL MANAGEMENT, L.P. (3.21M shares), BlackRock, Inc. (2.42M shares), MENORA MIVTACHIM HOLDINGS LTD. (2.3M shares), Vestal Point Capital, LP (2.15M shares), TORONTO DOMINION BANK (1.75M shares), ACORN CAPITAL ADVISORS, LLC (1.52M shares), SILVERARC CAPITAL MANAGEMENT, LLC (1.38M shares), and Nantahala Capital Management, LLC (1.36M shares).
This table shows the top 139 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.